Global Osteoarthritis Therapeutics Market Size study & Forecast, by Anatomy (Knee Osteoarthritis, Hip Osteoarthritis, Hand Osteoarthritis, Small Joint Osteoarthritis) by Drug Type (Viscosupplementation Agents, Non-steroidal Anti-inflammatory Drugs, Analgesics,Corticosteroids), by Distribution Channel (Hospitals Pharmacies, Retail Pharmacies, Online Pharmacies) and Regional Analysis, 2022-2029
Global Osteoarthritis Therapeutics Market is valued approximately USD 7348.46 million in 2021 and is anticipated to grow with a healthy growth rate of more than 8.8% over the forecast period 2022-2029. One of the most prevalent chronic health disorders, osteoarthritis is characterised by persistent pain, impairment, and decreased mobility. It is a degenerative condition of the joints that worsens with time and is brought on by the deterioration and eventual loss of cartilage in one or more joints. An example of cartilage is present in the joints between bones include the knee, ankle, and elbow. It assists in lubricating the joint and lowering friction. Treatment for osteoarthritis aims to reduce pain and improve functional status. The Osteoarthritis Therapeutics market is expanding because of factors such as Increasing prevalence of osteoarthritis and Growing population susceptible to osteoarthritis.
According to Centers for Disease Control and Prevention, in year 2020, there were around 63 million people in US had diagnosed with arthritis which is expected to reach at 78 million by year 2045. Thus rising prevelance of osteoarthritis is propelling the market growth. The Journal of EClinical Medicine stated in 2020 that roughly 22% of people over 40 years of age worldwide have been diagnosed with knee osteoarthritis. According to the World Bank Group, the world old population was 727 million in 2020, and it is predicted to treble over the next three decades, reaching 1.5 billion in 2050. Thus rising geriatric population in the region is further escalating the market growth. In addition, Rising number of sports injuries and development of Personalized medicines for osteoarthritis is creating a lucrative growth to the market. However, Risk of adverse cardiovascular events associated with the use of NSAIDs in osteoarthritis treatment and Commercialization of alternatives may hamper the market growth.
The key regions considered for the Global Osteoarthritis Therapeutics Market study includes Asia Pacific, North America, Europe, Latin America, and Rest of the World. North America dominated the market in terms of revenue, owing to the dominance of key market players and the region's increasing disease prevalence. Whereas Asia Pacific is expected to grow with a highest CAGR during the forecast period, owing to factors such as rising geriatric and target populations, an increase in the number of collaborations for product development, geographic expansion of key players, and active participation of government and nonprofit organizations in the market space.
Major market player included in this report are:
Pfizer, Inc
Eli Lilly and Company
Horizon Therapeutics plc
Ferring B.V.
Merck Sharp & Dohme Corp.
GlaxoSmithKline Plc.
Johnson & Johnson Private Limited
Bayer AG
Novartis AG
Pacira Pharmaceuticals, Inc
Recent Developments in the Market:
In January 2023, Arugula Sciences, LLC announced that it had received FDA permission for a Phase 1 clinical trial in the US for its first therapeutic product, Signature Cord PrimeTM. This was accomplished in partnership with its clinical partners. For patients with symptomatic knee osteoarthritis, this Phase 1 research is an open-label, dosage-ranging evaluation of safety, tolerability, preliminary effectiveness, and dose effects.
In February 2022, Alkem Laboratories announced that the Drug Controller General of India (DCGI) had approved the marketing of StemOne in India. The product is suggested for a variety of conditions, including knee osteoarthritis. It is the first allogeneic cell therapy product to be given commercial approval in India for the treatment of osteoarthritis of the knee.
Global Osteoarthritis Therapeutics Market Report Scope:
Historical Data 2019-2020-2021
Base Year for Estimation 2021
Forecast period 2022-2029
Report Coverage Revenue forecast, Company Ranking, Competitive Landscape, Growth factors, and Trends
Segments Covered Anatomy, Drug Type, Distribution Channel, Region
Regional Scope North America; Europe; Asia Pacific; Latin America; Rest of the World
Customization Scope Free report customization (equivalent up to 8 analyst’s working hours) with purchase. Addition or alteration to country, regional & segment scope*
The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within countries involved in the study.
The report also caters detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, it also incorporates potential opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and Anatomy offerings of key players. The detailed segments and sub-segment of the market are explained below:
By Anatomy:
Knee Osteoarthritis
Hip Osteoarthritis
Hand Osteoarthritis
Small Joint Osteoarthritis
By Drug Type:
Viscosupplementation Agents
Non-steroidal Anti-inflammatory Drugs
Analgesics
Corticosteroids
By Distribution Channel:
Hospitals Pharmacies
Retail Pharmacies
Online Pharmacies
By Region:
North America
U.S.
Canada
Europe
UK
Germany
France
Spain
Italy
ROE
Asia Pacific
China
India
Japan
Australia
South Korea
RoAPAC
Latin America
Brazil
Mexico
RoLA
Rest of the World
According to Centers for Disease Control and Prevention, in year 2020, there were around 63 million people in US had diagnosed with arthritis which is expected to reach at 78 million by year 2045. Thus rising prevelance of osteoarthritis is propelling the market growth. The Journal of EClinical Medicine stated in 2020 that roughly 22% of people over 40 years of age worldwide have been diagnosed with knee osteoarthritis. According to the World Bank Group, the world old population was 727 million in 2020, and it is predicted to treble over the next three decades, reaching 1.5 billion in 2050. Thus rising geriatric population in the region is further escalating the market growth. In addition, Rising number of sports injuries and development of Personalized medicines for osteoarthritis is creating a lucrative growth to the market. However, Risk of adverse cardiovascular events associated with the use of NSAIDs in osteoarthritis treatment and Commercialization of alternatives may hamper the market growth.
The key regions considered for the Global Osteoarthritis Therapeutics Market study includes Asia Pacific, North America, Europe, Latin America, and Rest of the World. North America dominated the market in terms of revenue, owing to the dominance of key market players and the region's increasing disease prevalence. Whereas Asia Pacific is expected to grow with a highest CAGR during the forecast period, owing to factors such as rising geriatric and target populations, an increase in the number of collaborations for product development, geographic expansion of key players, and active participation of government and nonprofit organizations in the market space.
Major market player included in this report are:
Pfizer, Inc
Eli Lilly and Company
Horizon Therapeutics plc
Ferring B.V.
Merck Sharp & Dohme Corp.
GlaxoSmithKline Plc.
Johnson & Johnson Private Limited
Bayer AG
Novartis AG
Pacira Pharmaceuticals, Inc
Recent Developments in the Market:
In January 2023, Arugula Sciences, LLC announced that it had received FDA permission for a Phase 1 clinical trial in the US for its first therapeutic product, Signature Cord PrimeTM. This was accomplished in partnership with its clinical partners. For patients with symptomatic knee osteoarthritis, this Phase 1 research is an open-label, dosage-ranging evaluation of safety, tolerability, preliminary effectiveness, and dose effects.
In February 2022, Alkem Laboratories announced that the Drug Controller General of India (DCGI) had approved the marketing of StemOne in India. The product is suggested for a variety of conditions, including knee osteoarthritis. It is the first allogeneic cell therapy product to be given commercial approval in India for the treatment of osteoarthritis of the knee.
Global Osteoarthritis Therapeutics Market Report Scope:
Historical Data 2019-2020-2021
Base Year for Estimation 2021
Forecast period 2022-2029
Report Coverage Revenue forecast, Company Ranking, Competitive Landscape, Growth factors, and Trends
Segments Covered Anatomy, Drug Type, Distribution Channel, Region
Regional Scope North America; Europe; Asia Pacific; Latin America; Rest of the World
Customization Scope Free report customization (equivalent up to 8 analyst’s working hours) with purchase. Addition or alteration to country, regional & segment scope*
The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within countries involved in the study.
The report also caters detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, it also incorporates potential opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and Anatomy offerings of key players. The detailed segments and sub-segment of the market are explained below:
By Anatomy:
Knee Osteoarthritis
Hip Osteoarthritis
Hand Osteoarthritis
Small Joint Osteoarthritis
By Drug Type:
Viscosupplementation Agents
Non-steroidal Anti-inflammatory Drugs
Analgesics
Corticosteroids
By Distribution Channel:
Hospitals Pharmacies
Retail Pharmacies
Online Pharmacies
By Region:
North America
U.S.
Canada
Europe
UK
Germany
France
Spain
Italy
ROE
Asia Pacific
China
India
Japan
Australia
South Korea
RoAPAC
Latin America
Brazil
Mexico
RoLA
Rest of the World
CHAPTER 1. EXECUTIVE SUMMARY
1.1. Market Snapshot
1.2. Global & Segmental Market Estimates & Forecasts, 2019-2029 (USD Million)
1.2.1. Osteoarthritis Therapeutics Market, by Region, 2019-2029 (USD Million)
1.2.2. Osteoarthritis Therapeutics Market, by Anatomy , 2019-2029 (USD Million)
1.2.3. Osteoarthritis Therapeutics Market, by Drug Type, 2019-2029 (USD Million)
1.2.4. Osteoarthritis Therapeutics Market, by Distribution Channel, 2019-2029 (USD Million)
1.3. Key Trends
1.4. Estimation Methodology
1.5. Research Assumption
CHAPTER 2. GLOBAL OSTEOARTHRITIS THERAPEUTICS MARKET DEFINITION AND SCOPE
2.1. Objective of the Study
2.2. Market Definition & Scope
2.2.1. Scope of the Study
2.2.2. Industry Evolution
2.3. Years Considered for the Study
2.4. Currency Conversion Rates
CHAPTER 3. GLOBAL OSTEOARTHRITIS THERAPEUTICS MARKET DYNAMICS
3.1. Osteoarthritis Therapeutics Market Impact Analysis (2019-2029)
3.1.1. Market Drivers
3.1.1.1. Increasing prevalence of osteoarthritis
3.1.1.2. Growing population susceptible to osteoarthritis
3.1.2. Market Challenges
3.1.2.1. Risk of adverse cardiovascular events associated with the use of NSAIDs
3.1.2.2. Commercialization of alternatives
3.1.3. Market Opportunities
3.1.3.1. Rising number of sports injuries
3.1.3.2. Development of Personalized medicines
CHAPTER 4. GLOBAL OSTEOARTHRITIS THERAPEUTICS MARKET INDUSTRY ANALYSIS
4.1. Porter’s 5 Force Model
4.1.1. Bargaining Power of Suppliers
4.1.2. Bargaining Power of Buyers
4.1.3. Threat of New Entrants
4.1.4. Threat of Substitutes
4.1.5. Competitive Rivalry
4.2. Futuristic Approach to Porter’s 5 Force Model (2019-2029)
4.3. PEST Analysis
4.3.1. Political
4.3.2. Economical
4.3.3. Social
4.3.4. Technological
4.4. Top investment opportunity
4.5. Top winning strategies
4.6. Industry Experts Prospective
4.7. Analyst Recommendation & Conclusion
CHAPTER 5. RISK ASSESSMENT: COVID-19 IMPACT
5.1. Assessment of the overall impact of COVID-19 on the industry
5.2. Pre COVID-19 and post COVID-19 Market scenario
CHAPTER 6. GLOBAL OSTEOARTHRITIS THERAPEUTICS MARKET, BY ANATOMY
6.1. Market Snapshot
6.2. Global Osteoarthritis Therapeutics Market by Anatomy , Performance - Potential Analysis
6.3. Global Osteoarthritis Therapeutics Market Estimates & Forecasts by Anatomy 2019-2029 (USD Million)
6.4. Osteoarthritis Therapeutics Market, Sub Segment Analysis
6.4.1. Knee Osteoarthritis
6.4.2. Hip Osteoarthritis
6.4.3. Hand Osteoarthritis
6.4.4. Small Joint Osteoarthritis
CHAPTER 7. GLOBAL OSTEOARTHRITIS THERAPEUTICS MARKET, BY DRUG TYPE
7.1. Market Snapshot
7.2. Global Osteoarthritis Therapeutics Market by Drug Type, Performance - Potential Analysis
7.3. Global Osteoarthritis Therapeutics Market Estimates & Forecasts by Drug Type 2019-2029 (USD Million)
7.4. Osteoarthritis Therapeutics Market, Sub Segment Analysis
7.4.1. Viscosupplementation Agents
7.4.2. Non-steroidal Anti-inflammatory Drugs
7.4.3. Analgesics
7.4.4. Corticosteroids
CHAPTER 8. GLOBAL OSTEOARTHRITIS THERAPEUTICS MARKET, BY DISTRIBUTION CHANNEL
8.1. Market Snapshot
8.2. Global Osteoarthritis Therapeutics Market by Distribution Channel, Performance - Potential Analysis
8.3. Global Osteoarthritis Therapeutics Market Estimates & Forecasts by Distribution Channel 2019-2029 (USD Million)
8.4. Osteoarthritis Therapeutics Market, Sub Segment Analysis
8.4.1. Hospitals Pharmacies
8.4.2. Retail Pharmacies
8.4.3. Online Pharmacies
CHAPTER 9. GLOBAL OSTEOARTHRITIS THERAPEUTICS MARKET, REGIONAL ANALYSIS
9.1. Osteoarthritis Therapeutics Market, Regional Market Snapshot
9.2. North America Osteoarthritis Therapeutics Market
9.2.1. U.S. Osteoarthritis Therapeutics Market
9.2.1.1. Anatomy breakdown estimates & forecasts, 2019-2029
9.2.1.2. Drug Type breakdown estimates & forecasts, 2019-2029
9.2.1.3. Distribution Channel breakdown estimates & forecasts, 2019-2029
9.2.2. Canada Osteoarthritis Therapeutics Market
9.3. Europe Osteoarthritis Therapeutics Market Snapshot
9.3.1. U.K. Osteoarthritis Therapeutics Market
9.3.2. Germany Osteoarthritis Therapeutics Market
9.3.3. France Osteoarthritis Therapeutics Market
9.3.4. Spain Osteoarthritis Therapeutics Market
9.3.5. Italy Osteoarthritis Therapeutics Market
9.3.6. Rest of Europe Osteoarthritis Therapeutics Market
9.4. Asia-Pacific Osteoarthritis Therapeutics Market Snapshot
9.4.1. China Osteoarthritis Therapeutics Market
9.4.2. India Osteoarthritis Therapeutics Market
9.4.3. Japan Osteoarthritis Therapeutics Market
9.4.4. Australia Osteoarthritis Therapeutics Market
9.4.5. South Korea Osteoarthritis Therapeutics Market
9.4.6. Rest of Asia Pacific Osteoarthritis Therapeutics Market
9.5. Latin America Osteoarthritis Therapeutics Market Snapshot
9.5.1. Brazil Osteoarthritis Therapeutics Market
9.5.2. Mexico Osteoarthritis Therapeutics Market
9.5.3. Rest of Latin America Osteoarthritis Therapeutics Market
9.6. Rest of The World Osteoarthritis Therapeutics Market
CHAPTER 10. COMPETITIVE INTELLIGENCE
10.1. Top Market Strategies
10.2. Company Profiles
10.2.1. Pfizer, Inc
10.2.1.1. Key Information
10.2.1.2. Overview
10.2.1.3. Financial (Subject to Data Availability)
10.2.1.4. Product Summary
10.2.1.5. Recent Developments
10.2.2. Eli Lilly and Company
10.2.3. Horizon Therapeutics plc
10.2.4. Ferring B.V.
10.2.5. Merck Sharp & Dohme Corp.
10.2.6. GlaxoSmithKline Plc.
10.2.7. Johnson & Johnson Private Limited
10.2.8. Bayer AG
10.2.9. Novartis AG
10.2.10. Pacira Pharmaceuticals, Inc
CHAPTER 11. RESEARCH PROCESS
11.1. Research Process
11.1.1. Data Mining
11.1.2. Analysis
11.1.3. Market Estimation
11.1.4. Validation
11.1.5. Publishing
11.2. Research Attributes
11.3. Research Assumption
1.1. Market Snapshot
1.2. Global & Segmental Market Estimates & Forecasts, 2019-2029 (USD Million)
1.2.1. Osteoarthritis Therapeutics Market, by Region, 2019-2029 (USD Million)
1.2.2. Osteoarthritis Therapeutics Market, by Anatomy , 2019-2029 (USD Million)
1.2.3. Osteoarthritis Therapeutics Market, by Drug Type, 2019-2029 (USD Million)
1.2.4. Osteoarthritis Therapeutics Market, by Distribution Channel, 2019-2029 (USD Million)
1.3. Key Trends
1.4. Estimation Methodology
1.5. Research Assumption
CHAPTER 2. GLOBAL OSTEOARTHRITIS THERAPEUTICS MARKET DEFINITION AND SCOPE
2.1. Objective of the Study
2.2. Market Definition & Scope
2.2.1. Scope of the Study
2.2.2. Industry Evolution
2.3. Years Considered for the Study
2.4. Currency Conversion Rates
CHAPTER 3. GLOBAL OSTEOARTHRITIS THERAPEUTICS MARKET DYNAMICS
3.1. Osteoarthritis Therapeutics Market Impact Analysis (2019-2029)
3.1.1. Market Drivers
3.1.1.1. Increasing prevalence of osteoarthritis
3.1.1.2. Growing population susceptible to osteoarthritis
3.1.2. Market Challenges
3.1.2.1. Risk of adverse cardiovascular events associated with the use of NSAIDs
3.1.2.2. Commercialization of alternatives
3.1.3. Market Opportunities
3.1.3.1. Rising number of sports injuries
3.1.3.2. Development of Personalized medicines
CHAPTER 4. GLOBAL OSTEOARTHRITIS THERAPEUTICS MARKET INDUSTRY ANALYSIS
4.1. Porter’s 5 Force Model
4.1.1. Bargaining Power of Suppliers
4.1.2. Bargaining Power of Buyers
4.1.3. Threat of New Entrants
4.1.4. Threat of Substitutes
4.1.5. Competitive Rivalry
4.2. Futuristic Approach to Porter’s 5 Force Model (2019-2029)
4.3. PEST Analysis
4.3.1. Political
4.3.2. Economical
4.3.3. Social
4.3.4. Technological
4.4. Top investment opportunity
4.5. Top winning strategies
4.6. Industry Experts Prospective
4.7. Analyst Recommendation & Conclusion
CHAPTER 5. RISK ASSESSMENT: COVID-19 IMPACT
5.1. Assessment of the overall impact of COVID-19 on the industry
5.2. Pre COVID-19 and post COVID-19 Market scenario
CHAPTER 6. GLOBAL OSTEOARTHRITIS THERAPEUTICS MARKET, BY ANATOMY
6.1. Market Snapshot
6.2. Global Osteoarthritis Therapeutics Market by Anatomy , Performance - Potential Analysis
6.3. Global Osteoarthritis Therapeutics Market Estimates & Forecasts by Anatomy 2019-2029 (USD Million)
6.4. Osteoarthritis Therapeutics Market, Sub Segment Analysis
6.4.1. Knee Osteoarthritis
6.4.2. Hip Osteoarthritis
6.4.3. Hand Osteoarthritis
6.4.4. Small Joint Osteoarthritis
CHAPTER 7. GLOBAL OSTEOARTHRITIS THERAPEUTICS MARKET, BY DRUG TYPE
7.1. Market Snapshot
7.2. Global Osteoarthritis Therapeutics Market by Drug Type, Performance - Potential Analysis
7.3. Global Osteoarthritis Therapeutics Market Estimates & Forecasts by Drug Type 2019-2029 (USD Million)
7.4. Osteoarthritis Therapeutics Market, Sub Segment Analysis
7.4.1. Viscosupplementation Agents
7.4.2. Non-steroidal Anti-inflammatory Drugs
7.4.3. Analgesics
7.4.4. Corticosteroids
CHAPTER 8. GLOBAL OSTEOARTHRITIS THERAPEUTICS MARKET, BY DISTRIBUTION CHANNEL
8.1. Market Snapshot
8.2. Global Osteoarthritis Therapeutics Market by Distribution Channel, Performance - Potential Analysis
8.3. Global Osteoarthritis Therapeutics Market Estimates & Forecasts by Distribution Channel 2019-2029 (USD Million)
8.4. Osteoarthritis Therapeutics Market, Sub Segment Analysis
8.4.1. Hospitals Pharmacies
8.4.2. Retail Pharmacies
8.4.3. Online Pharmacies
CHAPTER 9. GLOBAL OSTEOARTHRITIS THERAPEUTICS MARKET, REGIONAL ANALYSIS
9.1. Osteoarthritis Therapeutics Market, Regional Market Snapshot
9.2. North America Osteoarthritis Therapeutics Market
9.2.1. U.S. Osteoarthritis Therapeutics Market
9.2.1.1. Anatomy breakdown estimates & forecasts, 2019-2029
9.2.1.2. Drug Type breakdown estimates & forecasts, 2019-2029
9.2.1.3. Distribution Channel breakdown estimates & forecasts, 2019-2029
9.2.2. Canada Osteoarthritis Therapeutics Market
9.3. Europe Osteoarthritis Therapeutics Market Snapshot
9.3.1. U.K. Osteoarthritis Therapeutics Market
9.3.2. Germany Osteoarthritis Therapeutics Market
9.3.3. France Osteoarthritis Therapeutics Market
9.3.4. Spain Osteoarthritis Therapeutics Market
9.3.5. Italy Osteoarthritis Therapeutics Market
9.3.6. Rest of Europe Osteoarthritis Therapeutics Market
9.4. Asia-Pacific Osteoarthritis Therapeutics Market Snapshot
9.4.1. China Osteoarthritis Therapeutics Market
9.4.2. India Osteoarthritis Therapeutics Market
9.4.3. Japan Osteoarthritis Therapeutics Market
9.4.4. Australia Osteoarthritis Therapeutics Market
9.4.5. South Korea Osteoarthritis Therapeutics Market
9.4.6. Rest of Asia Pacific Osteoarthritis Therapeutics Market
9.5. Latin America Osteoarthritis Therapeutics Market Snapshot
9.5.1. Brazil Osteoarthritis Therapeutics Market
9.5.2. Mexico Osteoarthritis Therapeutics Market
9.5.3. Rest of Latin America Osteoarthritis Therapeutics Market
9.6. Rest of The World Osteoarthritis Therapeutics Market
CHAPTER 10. COMPETITIVE INTELLIGENCE
10.1. Top Market Strategies
10.2. Company Profiles
10.2.1. Pfizer, Inc
10.2.1.1. Key Information
10.2.1.2. Overview
10.2.1.3. Financial (Subject to Data Availability)
10.2.1.4. Product Summary
10.2.1.5. Recent Developments
10.2.2. Eli Lilly and Company
10.2.3. Horizon Therapeutics plc
10.2.4. Ferring B.V.
10.2.5. Merck Sharp & Dohme Corp.
10.2.6. GlaxoSmithKline Plc.
10.2.7. Johnson & Johnson Private Limited
10.2.8. Bayer AG
10.2.9. Novartis AG
10.2.10. Pacira Pharmaceuticals, Inc
CHAPTER 11. RESEARCH PROCESS
11.1. Research Process
11.1.1. Data Mining
11.1.2. Analysis
11.1.3. Market Estimation
11.1.4. Validation
11.1.5. Publishing
11.2. Research Attributes
11.3. Research Assumption
LIST OF TABLES
TABLE 1. Global Osteoarthritis Therapeutics Market, report scope
TABLE 2. Global Osteoarthritis Therapeutics Market estimates & forecasts by Region 2019-2029 (USD Million)
TABLE 3. Global Osteoarthritis Therapeutics Market estimates & forecasts by Anatomy 2019-2029 (USD Million)
TABLE 4. Global Osteoarthritis Therapeutics Market estimates & forecasts by Drug Type 2019-2029 (USD Million)
TABLE 5. Global Osteoarthritis Therapeutics Market estimates & forecasts by Distribution Channel 2019-2029 (USD Million)
TABLE 6. Global Osteoarthritis Therapeutics Market by segment, estimates & forecasts, 2019-2029 (USD Million)
TABLE 7. Global Osteoarthritis Therapeutics Market by region, estimates & forecasts, 2019-2029 (USD Million)
TABLE 8. Global Osteoarthritis Therapeutics Market by segment, estimates & forecasts, 2019-2029 (USD Million)
TABLE 9. Global Osteoarthritis Therapeutics Market by region, estimates & forecasts, 2019-2029 (USD Million)
TABLE 10. Global Osteoarthritis Therapeutics Market by segment, estimates & forecasts, 2019-2029 (USD Million)
TABLE 11. Global Osteoarthritis Therapeutics Market by region, estimates & forecasts, 2019-2029 (USD Million)
TABLE 12. Global Osteoarthritis Therapeutics Market by segment, estimates & forecasts, 2019-2029 (USD Million)
TABLE 13. Global Osteoarthritis Therapeutics Market by region, estimates & forecasts, 2019-2029 (USD Million)
TABLE 14. Global Osteoarthritis Therapeutics Market by segment, estimates & forecasts, 2019-2029 (USD Million)
TABLE 15. Global Osteoarthritis Therapeutics Market by region, estimates & forecasts, 2019-2029 (USD Million)
TABLE 16. U.S. Osteoarthritis Therapeutics Market estimates & forecasts, 2019-2029 (USD Million)
TABLE 17. U.S. Osteoarthritis Therapeutics Market estimates & forecasts by segment 2019-2029 (USD Million)
TABLE 18. U.S. Osteoarthritis Therapeutics Market estimates & forecasts by segment 2019-2029 (USD Million)
TABLE 19. Canada Osteoarthritis Therapeutics Market estimates & forecasts, 2019-2029 (USD Million)
TABLE 20. Canada Osteoarthritis Therapeutics Market estimates & forecasts by segment 2019-2029 (USD Million)
TABLE 21. Canada Osteoarthritis Therapeutics Market estimates & forecasts by segment 2019-2029 (USD Million)
TABLE 22. UK Osteoarthritis Therapeutics Market estimates & forecasts, 2019-2029 (USD Million)
TABLE 23. UK Osteoarthritis Therapeutics Market estimates & forecasts by segment 2019-2029 (USD Million)
TABLE 24. UK Osteoarthritis Therapeutics Market estimates & forecasts by segment 2019-2029 (USD Million)
TABLE 25. Germany Osteoarthritis Therapeutics Market estimates & forecasts, 2019-2029 (USD Million)
TABLE 26. Germany Osteoarthritis Therapeutics Market estimates & forecasts by segment 2019-2029 (USD Million)
TABLE 27. Germany Osteoarthritis Therapeutics Market estimates & forecasts by segment 2019-2029 (USD Million)
TABLE 28. France Osteoarthritis Therapeutics Market estimates & forecasts, 2019-2029 (USD Million)
TABLE 29. France Osteoarthritis Therapeutics Market estimates & forecasts by segment 2019-2029 (USD Million)
TABLE 30. France Osteoarthritis Therapeutics Market estimates & forecasts by segment 2019-2029 (USD Million)
TABLE 31. Italy Osteoarthritis Therapeutics Market estimates & forecasts, 2019-2029 (USD Million)
TABLE 32. Italy Osteoarthritis Therapeutics Market estimates & forecasts by segment 2019-2029 (USD Million)
TABLE 33. Italy Osteoarthritis Therapeutics Market estimates & forecasts by segment 2019-2029 (USD Million)
TABLE 34. Spain Osteoarthritis Therapeutics Market estimates & forecasts, 2019-2029 (USD Million)
TABLE 35. Spain Osteoarthritis Therapeutics Market estimates & forecasts by segment 2019-2029 (USD Million)
TABLE 36. Spain Osteoarthritis Therapeutics Market estimates & forecasts by segment 2019-2029 (USD Million)
TABLE 37. RoE Osteoarthritis Therapeutics Market estimates & forecasts, 2019-2029 (USD Million)
TABLE 38. RoE Osteoarthritis Therapeutics Market estimates & forecasts by segment 2019-2029 (USD Million)
TABLE 39. RoE Osteoarthritis Therapeutics Market estimates & forecasts by segment 2019-2029 (USD Million)
TABLE 40. China Osteoarthritis Therapeutics Market estimates & forecasts, 2019-2029 (USD Million)
TABLE 41. China Osteoarthritis Therapeutics Market estimates & forecasts by segment 2019-2029 (USD Million)
TABLE 42. China Osteoarthritis Therapeutics Market estimates & forecasts by segment 2019-2029 (USD Million)
TABLE 43. India Osteoarthritis Therapeutics Market estimates & forecasts, 2019-2029 (USD Million)
TABLE 44. India Osteoarthritis Therapeutics Market estimates & forecasts by segment 2019-2029 (USD Million)
TABLE 45. India Osteoarthritis Therapeutics Market estimates & forecasts by segment 2019-2029 (USD Million)
TABLE 46. Japan Osteoarthritis Therapeutics Market estimates & forecasts, 2019-2029 (USD Million)
TABLE 47. Japan Osteoarthritis Therapeutics Market estimates & forecasts by segment 2019-2029 (USD Million)
TABLE 48. Japan Osteoarthritis Therapeutics Market estimates & forecasts by segment 2019-2029 (USD Million)
TABLE 49. South Korea Osteoarthritis Therapeutics Market estimates & forecasts, 2019-2029 (USD Million)
TABLE 50. South Korea Osteoarthritis Therapeutics Market estimates & forecasts by segment 2019-2029 (USD Million)
TABLE 51. South Korea Osteoarthritis Therapeutics Market estimates & forecasts by segment 2019-2029 (USD Million)
TABLE 52. Australia Osteoarthritis Therapeutics Market estimates & forecasts, 2019-2029 (USD Million)
TABLE 53. Australia Osteoarthritis Therapeutics Market estimates & forecasts by segment 2019-2029 (USD Million)
TABLE 54. Australia Osteoarthritis Therapeutics Market estimates & forecasts by segment 2019-2029 (USD Million)
TABLE 55. RoAPAC Osteoarthritis Therapeutics Market estimates & forecasts, 2019-2029 (USD Million)
TABLE 56. RoAPAC Osteoarthritis Therapeutics Market estimates & forecasts by segment 2019-2029 (USD Million)
TABLE 57. RoAPAC Osteoarthritis Therapeutics Market estimates & forecasts by segment 2019-2029 (USD Million)
TABLE 58. Brazil Osteoarthritis Therapeutics Market estimates & forecasts, 2019-2029 (USD Million)
TABLE 59. Brazil Osteoarthritis Therapeutics Market estimates & forecasts by segment 2019-2029 (USD Million)
TABLE 60. Brazil Osteoarthritis Therapeutics Market estimates & forecasts by segment 2019-2029 (USD Million)
TABLE 61. Mexico Osteoarthritis Therapeutics Market estimates & forecasts, 2019-2029 (USD Million)
TABLE 62. Mexico Osteoarthritis Therapeutics Market estimates & forecasts by segment 2019-2029 (USD Million)
TABLE 63. Mexico Osteoarthritis Therapeutics Market estimates & forecasts by segment 2019-2029 (USD Million)
TABLE 64. RoLA Osteoarthritis Therapeutics Market estimates & forecasts, 2019-2029 (USD Million)
TABLE 65. RoLA Osteoarthritis Therapeutics Market estimates & forecasts by segment 2019-2029 (USD Million)
TABLE 66. RoLA Osteoarthritis Therapeutics Market estimates & forecasts by segment 2019-2029 (USD Million)
TABLE 67. Row Osteoarthritis Therapeutics Market estimates & forecasts, 2019-2029 (USD Million)
TABLE 68. Row Osteoarthritis Therapeutics Market estimates & forecasts by segment 2019-2029 (USD Million)
TABLE 69. Row Osteoarthritis Therapeutics Market estimates & forecasts by segment 2019-2029 (USD Million)
TABLE 70. List of secondary sources, used in the study of global Osteoarthritis Therapeutics Market
TABLE 71. List of primary sources, used in the study of global Osteoarthritis Therapeutics Market
TABLE 72. Years considered for the study
TABLE 73. Exchange rates considered
List of tables and figures and dummy in nature, final lists may vary in the final deliverable
TABLE 1. Global Osteoarthritis Therapeutics Market, report scope
TABLE 2. Global Osteoarthritis Therapeutics Market estimates & forecasts by Region 2019-2029 (USD Million)
TABLE 3. Global Osteoarthritis Therapeutics Market estimates & forecasts by Anatomy 2019-2029 (USD Million)
TABLE 4. Global Osteoarthritis Therapeutics Market estimates & forecasts by Drug Type 2019-2029 (USD Million)
TABLE 5. Global Osteoarthritis Therapeutics Market estimates & forecasts by Distribution Channel 2019-2029 (USD Million)
TABLE 6. Global Osteoarthritis Therapeutics Market by segment, estimates & forecasts, 2019-2029 (USD Million)
TABLE 7. Global Osteoarthritis Therapeutics Market by region, estimates & forecasts, 2019-2029 (USD Million)
TABLE 8. Global Osteoarthritis Therapeutics Market by segment, estimates & forecasts, 2019-2029 (USD Million)
TABLE 9. Global Osteoarthritis Therapeutics Market by region, estimates & forecasts, 2019-2029 (USD Million)
TABLE 10. Global Osteoarthritis Therapeutics Market by segment, estimates & forecasts, 2019-2029 (USD Million)
TABLE 11. Global Osteoarthritis Therapeutics Market by region, estimates & forecasts, 2019-2029 (USD Million)
TABLE 12. Global Osteoarthritis Therapeutics Market by segment, estimates & forecasts, 2019-2029 (USD Million)
TABLE 13. Global Osteoarthritis Therapeutics Market by region, estimates & forecasts, 2019-2029 (USD Million)
TABLE 14. Global Osteoarthritis Therapeutics Market by segment, estimates & forecasts, 2019-2029 (USD Million)
TABLE 15. Global Osteoarthritis Therapeutics Market by region, estimates & forecasts, 2019-2029 (USD Million)
TABLE 16. U.S. Osteoarthritis Therapeutics Market estimates & forecasts, 2019-2029 (USD Million)
TABLE 17. U.S. Osteoarthritis Therapeutics Market estimates & forecasts by segment 2019-2029 (USD Million)
TABLE 18. U.S. Osteoarthritis Therapeutics Market estimates & forecasts by segment 2019-2029 (USD Million)
TABLE 19. Canada Osteoarthritis Therapeutics Market estimates & forecasts, 2019-2029 (USD Million)
TABLE 20. Canada Osteoarthritis Therapeutics Market estimates & forecasts by segment 2019-2029 (USD Million)
TABLE 21. Canada Osteoarthritis Therapeutics Market estimates & forecasts by segment 2019-2029 (USD Million)
TABLE 22. UK Osteoarthritis Therapeutics Market estimates & forecasts, 2019-2029 (USD Million)
TABLE 23. UK Osteoarthritis Therapeutics Market estimates & forecasts by segment 2019-2029 (USD Million)
TABLE 24. UK Osteoarthritis Therapeutics Market estimates & forecasts by segment 2019-2029 (USD Million)
TABLE 25. Germany Osteoarthritis Therapeutics Market estimates & forecasts, 2019-2029 (USD Million)
TABLE 26. Germany Osteoarthritis Therapeutics Market estimates & forecasts by segment 2019-2029 (USD Million)
TABLE 27. Germany Osteoarthritis Therapeutics Market estimates & forecasts by segment 2019-2029 (USD Million)
TABLE 28. France Osteoarthritis Therapeutics Market estimates & forecasts, 2019-2029 (USD Million)
TABLE 29. France Osteoarthritis Therapeutics Market estimates & forecasts by segment 2019-2029 (USD Million)
TABLE 30. France Osteoarthritis Therapeutics Market estimates & forecasts by segment 2019-2029 (USD Million)
TABLE 31. Italy Osteoarthritis Therapeutics Market estimates & forecasts, 2019-2029 (USD Million)
TABLE 32. Italy Osteoarthritis Therapeutics Market estimates & forecasts by segment 2019-2029 (USD Million)
TABLE 33. Italy Osteoarthritis Therapeutics Market estimates & forecasts by segment 2019-2029 (USD Million)
TABLE 34. Spain Osteoarthritis Therapeutics Market estimates & forecasts, 2019-2029 (USD Million)
TABLE 35. Spain Osteoarthritis Therapeutics Market estimates & forecasts by segment 2019-2029 (USD Million)
TABLE 36. Spain Osteoarthritis Therapeutics Market estimates & forecasts by segment 2019-2029 (USD Million)
TABLE 37. RoE Osteoarthritis Therapeutics Market estimates & forecasts, 2019-2029 (USD Million)
TABLE 38. RoE Osteoarthritis Therapeutics Market estimates & forecasts by segment 2019-2029 (USD Million)
TABLE 39. RoE Osteoarthritis Therapeutics Market estimates & forecasts by segment 2019-2029 (USD Million)
TABLE 40. China Osteoarthritis Therapeutics Market estimates & forecasts, 2019-2029 (USD Million)
TABLE 41. China Osteoarthritis Therapeutics Market estimates & forecasts by segment 2019-2029 (USD Million)
TABLE 42. China Osteoarthritis Therapeutics Market estimates & forecasts by segment 2019-2029 (USD Million)
TABLE 43. India Osteoarthritis Therapeutics Market estimates & forecasts, 2019-2029 (USD Million)
TABLE 44. India Osteoarthritis Therapeutics Market estimates & forecasts by segment 2019-2029 (USD Million)
TABLE 45. India Osteoarthritis Therapeutics Market estimates & forecasts by segment 2019-2029 (USD Million)
TABLE 46. Japan Osteoarthritis Therapeutics Market estimates & forecasts, 2019-2029 (USD Million)
TABLE 47. Japan Osteoarthritis Therapeutics Market estimates & forecasts by segment 2019-2029 (USD Million)
TABLE 48. Japan Osteoarthritis Therapeutics Market estimates & forecasts by segment 2019-2029 (USD Million)
TABLE 49. South Korea Osteoarthritis Therapeutics Market estimates & forecasts, 2019-2029 (USD Million)
TABLE 50. South Korea Osteoarthritis Therapeutics Market estimates & forecasts by segment 2019-2029 (USD Million)
TABLE 51. South Korea Osteoarthritis Therapeutics Market estimates & forecasts by segment 2019-2029 (USD Million)
TABLE 52. Australia Osteoarthritis Therapeutics Market estimates & forecasts, 2019-2029 (USD Million)
TABLE 53. Australia Osteoarthritis Therapeutics Market estimates & forecasts by segment 2019-2029 (USD Million)
TABLE 54. Australia Osteoarthritis Therapeutics Market estimates & forecasts by segment 2019-2029 (USD Million)
TABLE 55. RoAPAC Osteoarthritis Therapeutics Market estimates & forecasts, 2019-2029 (USD Million)
TABLE 56. RoAPAC Osteoarthritis Therapeutics Market estimates & forecasts by segment 2019-2029 (USD Million)
TABLE 57. RoAPAC Osteoarthritis Therapeutics Market estimates & forecasts by segment 2019-2029 (USD Million)
TABLE 58. Brazil Osteoarthritis Therapeutics Market estimates & forecasts, 2019-2029 (USD Million)
TABLE 59. Brazil Osteoarthritis Therapeutics Market estimates & forecasts by segment 2019-2029 (USD Million)
TABLE 60. Brazil Osteoarthritis Therapeutics Market estimates & forecasts by segment 2019-2029 (USD Million)
TABLE 61. Mexico Osteoarthritis Therapeutics Market estimates & forecasts, 2019-2029 (USD Million)
TABLE 62. Mexico Osteoarthritis Therapeutics Market estimates & forecasts by segment 2019-2029 (USD Million)
TABLE 63. Mexico Osteoarthritis Therapeutics Market estimates & forecasts by segment 2019-2029 (USD Million)
TABLE 64. RoLA Osteoarthritis Therapeutics Market estimates & forecasts, 2019-2029 (USD Million)
TABLE 65. RoLA Osteoarthritis Therapeutics Market estimates & forecasts by segment 2019-2029 (USD Million)
TABLE 66. RoLA Osteoarthritis Therapeutics Market estimates & forecasts by segment 2019-2029 (USD Million)
TABLE 67. Row Osteoarthritis Therapeutics Market estimates & forecasts, 2019-2029 (USD Million)
TABLE 68. Row Osteoarthritis Therapeutics Market estimates & forecasts by segment 2019-2029 (USD Million)
TABLE 69. Row Osteoarthritis Therapeutics Market estimates & forecasts by segment 2019-2029 (USD Million)
TABLE 70. List of secondary sources, used in the study of global Osteoarthritis Therapeutics Market
TABLE 71. List of primary sources, used in the study of global Osteoarthritis Therapeutics Market
TABLE 72. Years considered for the study
TABLE 73. Exchange rates considered
List of tables and figures and dummy in nature, final lists may vary in the final deliverable
LIST OF FIGURES
FIG 1. Global Osteoarthritis Therapeutics Market, research methodology
FIG 2. Global Osteoarthritis Therapeutics Market, Market estimation techniques
FIG 3. Global Market size estimates & forecast methods
FIG 4. Global Osteoarthritis Therapeutics Market, key trends 2021
FIG 5. Global Osteoarthritis Therapeutics Market, growth prospects 2022-2029
FIG 6. Global Osteoarthritis Therapeutics Market, porters 5 force model
FIG 7. Global Osteoarthritis Therapeutics Market, pest analysis
FIG 8. Global Osteoarthritis Therapeutics Market, value chain analysis
FIG 9. Global Osteoarthritis Therapeutics Market by segment, 2019 & 2029 (USD Million)
FIG 10. Global Osteoarthritis Therapeutics Market by segment, 2019 & 2029 (USD Million)
FIG 11. Global Osteoarthritis Therapeutics Market by segment, 2019 & 2029 (USD Million)
FIG 12. Global Osteoarthritis Therapeutics Market by segment, 2019 & 2029 (USD Million)
FIG 13. Global Osteoarthritis Therapeutics Market by segment, 2019 & 2029 (USD Million)
FIG 14. Global Osteoarthritis Therapeutics Market, regional snapshot 2019 & 2029
FIG 15. North America Osteoarthritis Therapeutics Market 2019 & 2029 (USD Million)
FIG 16. Europe Osteoarthritis Therapeutics Market 2019 & 2029 (USD Million)
FIG 17. Asia pacific Osteoarthritis Therapeutics Market 2019 & 2029 (USD Million)
FIG 18. Latin America Osteoarthritis Therapeutics Market 2019 & 2029 (USD Million)
FIG 19. Global Osteoarthritis Therapeutics Market, company Market share analysis (2021)
List of tables and figures and dummy in nature, final lists may vary in the final deliverable
FIG 1. Global Osteoarthritis Therapeutics Market, research methodology
FIG 2. Global Osteoarthritis Therapeutics Market, Market estimation techniques
FIG 3. Global Market size estimates & forecast methods
FIG 4. Global Osteoarthritis Therapeutics Market, key trends 2021
FIG 5. Global Osteoarthritis Therapeutics Market, growth prospects 2022-2029
FIG 6. Global Osteoarthritis Therapeutics Market, porters 5 force model
FIG 7. Global Osteoarthritis Therapeutics Market, pest analysis
FIG 8. Global Osteoarthritis Therapeutics Market, value chain analysis
FIG 9. Global Osteoarthritis Therapeutics Market by segment, 2019 & 2029 (USD Million)
FIG 10. Global Osteoarthritis Therapeutics Market by segment, 2019 & 2029 (USD Million)
FIG 11. Global Osteoarthritis Therapeutics Market by segment, 2019 & 2029 (USD Million)
FIG 12. Global Osteoarthritis Therapeutics Market by segment, 2019 & 2029 (USD Million)
FIG 13. Global Osteoarthritis Therapeutics Market by segment, 2019 & 2029 (USD Million)
FIG 14. Global Osteoarthritis Therapeutics Market, regional snapshot 2019 & 2029
FIG 15. North America Osteoarthritis Therapeutics Market 2019 & 2029 (USD Million)
FIG 16. Europe Osteoarthritis Therapeutics Market 2019 & 2029 (USD Million)
FIG 17. Asia pacific Osteoarthritis Therapeutics Market 2019 & 2029 (USD Million)
FIG 18. Latin America Osteoarthritis Therapeutics Market 2019 & 2029 (USD Million)
FIG 19. Global Osteoarthritis Therapeutics Market, company Market share analysis (2021)
List of tables and figures and dummy in nature, final lists may vary in the final deliverable
